Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;19(5):1160-6.
doi: 10.1158/1055-9965.EPI-09-1303.

Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites

Affiliations

Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites

Neal L Benowitz et al. Cancer Epidemiol Biomarkers Prev. 2010 May.

Abstract

Background: We sought to determine the optimal plasma and urine nicotine metabolites, alone or in combination, to estimate the systemic dose of nicotine after low-level exposure.

Methods: We dosed 36 nonsmokers with 100, 200, or 400 microg p.o. of deuterium-labeled nicotine (doses similar to exposure to secondhand smoke) daily for 5 days and then measured plasma and urine nicotine metabolites at various intervals over 24 hours.

Results: The strongest correlations with nicotine dose were seen for the sum of four (cotinine+cotinine-glucuronide+trans-3'-hydroxycotinine+3HC-glucuronide) or six (including also nicotine+nicotine-glucuronide) of the major nicotine metabolites in 24-hour urine collection (r=0.96), with lesser correlations for these metabolites using spot urines corrected for creatinine at various times of day (r=0.72-0.80). The sum of plasma cotinine+trans-3'-hydroxycotine was more highly correlated with nicotine dose than plasma cotinine alone (r=0.82 versus 0.75).

Conclusions: Our results provide guidance for the selection of biomarkers to estimate the dose of nicotine taken in low-level (secondhand smoke) tobacco exposure.

Impact: This is probably relevant to active smoking as well.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean Plasma COT and 3HC 200 μg dose Average plasma concentrations of cotinine and trans-3′ hydroxycotinine sampled at various times of day in 12 subjects receiving 200 μg nicotine per day.
Figure 2
Figure 2
ALL urine metabolites (24 hr) 200 μg dose Average urine metabolites in 24 hour samples in 12 subjects receiving 200 μg nicotine per day. Analytes present at levels less than 3% of the nicotine were combined. This included nicotine N- oxide, cotinine N – oxide, nornicotine, nornicotine glucuronide, norcotinine and norcotinine glucuronide
Figure 3
Figure 3
Figure 3a. Urine - COT by dose (24 hr) Figure 3b. Urine - sum of nicotine metabolites by dose (24 hr) Correlations between daily dose of nicotine and urine cotinine (3a) and sum of nicotine metabolites [Nic + Nic-G + Cot + Cot-G + 3HC + 3HC-G] in 24 hour urine.
Figure 3
Figure 3
Figure 3a. Urine - COT by dose (24 hr) Figure 3b. Urine - sum of nicotine metabolites by dose (24 hr) Correlations between daily dose of nicotine and urine cotinine (3a) and sum of nicotine metabolites [Nic + Nic-G + Cot + Cot-G + 3HC + 3HC-G] in 24 hour urine.

Similar articles

Cited by

References

    1. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18:188–204. - PubMed
    1. Benowitz NL, Dains KM, Dempsey D, Herrera B, Yu L, Jacob P., 3rd Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure. Nicotine Tob Res. 2009;11:954–60. - PMC - PubMed
    1. Benowitz NL, Jacob P, III, Fong I, Gupta S. Nicotine metabolic profile in man: Comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther. 1994;268:296–303. - PubMed
    1. Joseph AM, Hecht SS, Murphy SE, et al. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure. Cancer Epidemiol Biomarkers Prev. 2005;14:2963–8. - PubMed
    1. Feng S, Kapur S, Sarkar M, et al. Respiratory retention of nicotine and urinary excretion of nicotine and its five major metabolites in adult male smokers. Toxicol Lett. 2007;173:101–6. - PubMed

Publication types